Observational studyBMC nephrology2025

Utility of trimethylamine N-oxide (TMAO) as a biomarker for risk stratification in chronic kidney disease: a multicenter observational study.

Yuyan Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.